These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 12226787)
21. von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura. Sahud MA; Claster S; Liu L; Ero M; Harris K; Furlan M Br J Haematol; 2002 Mar; 116(4):909-11. PubMed ID: 11886400 [TBL] [Abstract][Full Text] [Related]
22. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature. Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394 [TBL] [Abstract][Full Text] [Related]
23. Recurrent thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus. Maruoka H; Koga T; Inoue Y; Honda S; Takeo M; Fukuda T; Aizawa H Mod Rheumatol; 2007; 17(5):426-8. PubMed ID: 17929138 [TBL] [Abstract][Full Text] [Related]
24. Acquired deficiency of von Willebrand factor-cleaving protease in a patient suffering from acute systemic lupus erythematosus. Güngör T; Furlan M; Lämmle B; Kuhn F; Seger RA Rheumatology (Oxford); 2001 Aug; 40(8):940-2. PubMed ID: 11511766 [No Abstract] [Full Text] [Related]
26. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245 [TBL] [Abstract][Full Text] [Related]
27. Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab. Ma W; Bai W; Wu X; Zhao J; Li M; Zeng X Lupus; 2020 Dec; 29(14):1961-1967. PubMed ID: 32838618 [TBL] [Abstract][Full Text] [Related]
28. Recurrent thrombotic thrombocytopenic purpura in a young boy with systemic lupus erythematosus. Yuen LK; Lai WM; Tong PC; Poon WT; Tse KC; Chiu MC J Clin Rheumatol; 2007 Aug; 13(4):224-8. PubMed ID: 17762461 [TBL] [Abstract][Full Text] [Related]
29. Recent advances in thrombotic thrombocytopenic purpura. Sadler JE; Moake JL; Miyata T; George JN Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695 [TBL] [Abstract][Full Text] [Related]
30. [Rituximab as effective therapy in very severe thrombotic thrombocytopenic purpura (TTP)]. Illner N; Wolf G Dtsch Med Wochenschr; 2010 May; 135(3):71-4. PubMed ID: 20077379 [TBL] [Abstract][Full Text] [Related]
31. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene]. Schiphorst RH; van de Kar NC; van den Heuvel LP Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551 [TBL] [Abstract][Full Text] [Related]
32. Thrombotic thrombocytopenic purpura and systemic lupus erythematosus: a rare and life-threatening association. El Khayat SS; Medkouri G; Etomba AM; Zamd M; Gharbi MB; Ramadani B Arab J Nephrol Transplant; 2012 May; 5(2):103-5. PubMed ID: 22612197 [TBL] [Abstract][Full Text] [Related]
33. Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus. Hundae A; Peskoe S; Grimsley E; Patel S South Med J; 2008 Sep; 101(9):943-4. PubMed ID: 18708978 [TBL] [Abstract][Full Text] [Related]
34. Risk factors and clinical profile of thrombotic thrombocytopenic purpura in systemic lupus erythematosus patients. Is this a distinctive clinical entity in the thrombotic microangiopathy spectrum?: a case control study. Merayo-Chalico J; Demichelis-Gómez R; Rajme-López S; Aparicio-Vera L; Barrera-Vargas A; Alcocer-Varela J; Gómez-Martín D Thromb Res; 2014 Nov; 134(5):1020-7. PubMed ID: 25257921 [TBL] [Abstract][Full Text] [Related]
36. [A study on the significance of plasma thrombospondin1 in thrombotic thrombocytopenic purpura and the relationship between thrombospondin1 and von Willebrand factor cleaving protease (ADAMTS13)]. Liu F; Lu GY; Dong NZ; Bai X; Su J; Ruan CG Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3190-3. PubMed ID: 16405838 [TBL] [Abstract][Full Text] [Related]
37. Systemic lupus erythematosus and thrombotic thrombocytopenia purpura: a refractory case without lupus activity. Garcia Boyero R; Mas Esteve E; Mas Esteve M; Millá Perseguer MM; Marco Buades J; Beltran Fabregat J; Cañigral Ferrando G; Belmonte Serrano MA Reumatol Clin; 2013; 9(6):373-5. PubMed ID: 23473755 [TBL] [Abstract][Full Text] [Related]
38. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Rieger M; Mannucci PM; Kremer Hovinga JA; Herzog A; Gerstenbauer G; Konetschny C; Zimmermann K; Scharrer I; Peyvandi F; Galbusera M; Remuzzi G; Böhm M; Plaimauer B; Lämmle B; Scheiflinger F Blood; 2005 Aug; 106(4):1262-7. PubMed ID: 15890682 [TBL] [Abstract][Full Text] [Related]